This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Hokkaido University, Shionogi & Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 442 
1 out of 14 Years Active: 2026
Title: Takahiro Suto: Innovator in Pharmaceutical Research
Introduction
Takahiro Suto is an inventor based in Osaka-shi, Osaka, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds with antiviral properties. Although he currently holds no granted patents, his work is noteworthy for its potential impact on public health.
Latest Patent Applications
Takahiro Suto's latest patent application is titled "Triazine Derivatives Having Virus Replication Inhibitory Activity and Pharmaceutical Composition Comprising the Same." This application presents a compound that exhibits coronavirus 3CL protease inhibitory activity or a pharmaceutically acceptable salt thereof. Additionally, it includes a pharmaceutical composition comprising the same. The invention also provides a crystalline form useful as an active pharmaceutical ingredient.
Conclusion
Takahiro Suto's innovative research in antiviral compounds highlights his commitment to advancing pharmaceutical science. His contributions may pave the way for future developments in treating viral infections.